ALL ABOUT PROSTATE CANCER

Prevent prostate cancer with antioxidants? Gene pathway may reveal more clues
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage. The pathway, which is also involved in human prostate cancer, may help determine how and whether antioxidants, such as certain vitamins or their products that reverse the damage, can prevent prostate cancer…

Speed of PSA increase matters more than PSA level
In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions…

Vitamin D plus taxotere extends lives of men with advanced prostate cancer
Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study. The pill is DN-101. Designed specifically as a cancer therapy, it is a unique form of calcitriol, a naturally occurring hormone and the biologically active form of vitamin D…

Prostate Cancer - HIFU Sonablate(R) 500 Receives TGA Market Approval in Australia
THS International, Inc, theexclusive distributor for the advanced HIFU Sonablate(R) 500 in Asia andAustralia, announces that the Therapeutic Goods Administration (TGA) inAustralia has given full market approval to the Sonablate(R) 500, which hasbeen used for the minimally invasive treatment of prostate cancer…

X-ing out hereditary prostate cancer
According to the Prostate Cancer Foundation, one of every six American men develops prostate cancer, making it the most common form of non-skin cancer. Growing evidence suggests that there is a significant hereditary component to the disease, and one of the most strongly associated genomic regions lies on the X chromosome…

Prevent prostate cancer with antioxidants? Gene pathway may reveal more clues
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage. The pathway, which is also involved in human prostate cancer, may help determine how and whether antioxidants, such as certain vitamins or their products that reverse the damage, can prevent prostate cancer…

Prostate Cancer - Casodex 150mg plus Radiotherapy Extends Life Much More than Radiotherapy Alone
New data resulting from the 3rd analysis of the Early Prostate Cancer (EPC) Trial Programme confirm that bicalutamide 150mg improves the chance of survival by more than one third (35 per cent) in men with locally advanced prostate cancer (when the disease has spread into the capsule of the prostate or through the prostate into the surrounding tissue) when given as adjuvant to radiotherapy, compared to radiotherapy alone…

Benefits of Zyflamend in the early treatment of prostate cancer, Columbia study
Data from the Columbia University Department of Urology demonstrates that Zyflamend , a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called “apoptosis.” The data, published in the October edition of Nutrition and Cancer, showed Zyflamend , a patented formulation from New Chapter, has the ability, in vitro, to reduce prostate cancer cell proliferation by as much as 78 percent and to induce cancer cell death or apoptosis…

Scientists Identify How Antibody Blocks Prostate Cancer Growth in Animal Models, May Lead to A New Targeted Therapy
Researchers at UCLA’s Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy. The antibody, called 1G8 and discovered by UCLA scientists, signals the prostate cancer cells to stop growing and die, said Dr…

A novel model to pinpoint human androgen receptor targets developed
Computational prediction and experimental verification of androgen receptor binding within the prostate cancer genome.A novel computational model to pinpoint androgen receptor targets within the human genome was recently reported by the joint team of Genomatix Software GmbH, Munich, Germany….

Vegan diet and exercise may stop or reverse prostate cancer progression
Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study. The research is the first randomized, controlled trial showing that lifestyle changes may affect the progression of any type of cancer…

Activated vitamin D and NSAIDs form one-two punch against prostate cancer cells
Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs, taken in combination, have been shown to act as a powerful one-two punch that knocks down the growth of prostate cancer cells. In a study published in the journal “Cancer Research”, scientists from Stanford University discovered that the amount of both — activated vitamin D, or calcitriol, and the NSAIDs — could be reduced by half to one-tenth the dosage to thwart prostate cancer cell growth in cell lines and primary tissue cultures…

How antibody blocks prostate cancer growth in animal models, UCLA
Discovery may lead to new molecularly targeted therapiesResearchers at UCLA’s Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy…

U-M scientists say fused genes trigger the development of prostate cancer
Discovery could lead to prostate-cancer-specific diagnostic test and more effective treatment - Scientists at the University of Michigan Medical School, in collaboration with researchers at Harvard’s Brigham and Women’s Hospital, have discovered a recurring pattern of scrambled chromosomes and abnormal gene activity that occurs only in prostate cancer…

Prostate Cancer - HIFU Sonablate(R) 500 Receives TGA Market Approval in Australia
THS International, Inc, theexclusive distributor for the advanced HIFU Sonablate(R) 500 in Asia andAustralia, announces that the Therapeutic Goods Administration (TGA) inAustralia has given full market approval to the Sonablate(R) 500, which hasbeen used for the minimally invasive treatment of prostate cancer…

Leukemia Drug Shows Modest Benefit for Prostate Cancer
Johns Hopkins Kimmel Cancer Center researchers have found that the leukemia drug imatinib (Gleevec), which is being tested in various cancers including colon, ovarian and pancreas, may not work alone against prostate cancer. Previous studies have already found that imatinib is ineffective for metastatic prostate cancer… .

Speed of PSA increase matters more than PSA level
In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions….

Long-term hormone use helps prostate cancer patients live longer
Doctors in Canada have discovered that treating high-risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer, have better control of their prostate specific antigen levels and lowers the rate of death specifically from prostate cancer, according to a study published in the November 1, 2005, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO…

Prostate Cancer - Hormone Treatments Before Radiation Now Considered Effective
Radiation oncologists have eagerly anticipated a follow-up to previous studies that implied radiation treatment for prostate cancer was less effective after the use of drugs to suppress hormones. Now, Johns Hopkins Kimmel Cancer Center scientists say their tests provide evidence that hormone therapy will not diminish the value of radiation…